Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases - Archive ouverte HAL Access content directly
Journal Articles European Journal of Internal Medicine Year : 2021

Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases

(1) , (1, 2) , (3) , (3) , (4) , (5) , , (6) , (2, 7) , (8) , (1)
1
2
3
4
5
6
7
8
Daniela Lakomy
Sabine Revuz
  • Function : Author
Not file

Dates and versions

hal-03504774 , version 1 (29-12-2021)

Identifiers

Cite

Paul Decker, Thomas Moulinet, Benjamin Lopez, Sylvain Dubucquoi, Bernard Bonnotte, et al.. Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases. European Journal of Internal Medicine, 2021, 91, pp.45-52. ⟨10.1016/j.ejim.2021.04.020⟩. ⟨hal-03504774⟩
24 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More